Explore more publications!
Switzerland Tech Review
Got News to Share?

Press Releases

Vidac Pharma to Present Company Progress at the 19th Annual European Life Sciences CEO Forum Organized by Sachs
7 hours ago

Vidac Pharma to Present Company Progress at the 19th Annual European Life Sciences CEO Forum Organized by Sachs

Neutral EIN Presswire
Bioengineering Market Size Worth USD 1,484.98 Billion by 2035 Driven by AI-Powered Drug Discovery and Gene Editing
an hour ago

Bioengineering Market Size Worth USD 1,484.98 Billion by 2035 Driven by AI-Powered Drug Discovery and Gene Editing

Indeterminate GlobeNewswire, Inc.
Overcoming structural barriers to the green transition
13 hours ago

Overcoming structural barriers to the green transition

Gov't Institution ECB - European Central Bank
Owner: European Union

ECB - European Central Bank

Gov't Institution
Owned By European Union (Central Banks of Member States)
Year Founded 1998
Website www.ecb.europa.eu
Domain Registration Year Indeterminate
Access Type open
Publication Location Germany, Frankfurt am Main

We welcome your feedback!
If you have comments or corrections, let us know.

Recycled Polyethylene for Sustainable Flexible Packaging Market Cost & Price Analysis, Key Players, Technology Trends, and Regional Outlook (2025–2035)
Feb. 13, 2026

Recycled Polyethylene for Sustainable Flexible Packaging Market Cost & Price Analysis, Key Players, Technology Trends, and Regional Outlook (2025–2035)

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Develops Coordinated Search Service Across 1,500+ Swiss Pension Institutions to Facilitate Second Pillar Asset Repatriation
Feb. 11, 2026

Swiss Serenity Develops Coordinated Search Service Across 1,500+ Swiss Pension Institutions to Facilitate Second Pillar Asset Repatriation

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Reaches Historic Milestone: 328 Million CHF in Second Pillar Assets Identified for More Than 110,000 Swiss Citizens
Feb. 9, 2026

Swiss Serenity Reaches Historic Milestone: 328 Million CHF in Second Pillar Assets Identified for More Than 110,000 Swiss Citizens

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Announces Partnership with a Recognized Swiss Asset Manager to Facilitate Vested Benefits Account Transfers
Feb. 9, 2026

Swiss Serenity Announces Partnership with a Recognized Swiss Asset Manager to Facilitate Vested Benefits Account Transfers

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Enhances Legal Compliance for Second Pillar Asset Repatriation for Switzerland
Feb. 9, 2026

Swiss Serenity Enhances Legal Compliance for Second Pillar Asset Repatriation for Switzerland

Indeterminate GlobeNewswire, Inc.
SEALSQ Presented at Tech&Fest How the Quantum Shield QS7001 Can be Integrated as a Hardware Root of Trust to Meet Cryptographic Transition New Legal Requirements Like CNSA 2.0
Feb. 11, 2026

SEALSQ Presented at Tech&Fest How the Quantum Shield QS7001 Can be Integrated as a Hardware Root of Trust to Meet Cryptographic Transition New Legal Requirements Like CNSA 2.0

Indeterminate GlobeNewswire, Inc.
InSphero and PharmaNest From a Partnership to Advance Translational Fibrosis Research
Feb. 11, 2026

InSphero and PharmaNest From a Partnership to Advance Translational Fibrosis Research

Neutral EIN Presswire
Research presented at the World Economic Forum points to global risks
Feb. 9, 2026

Research presented at the World Economic Forum points to global risks

Neutral EIN Presswire
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
Feb. 9, 2026

Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology

Indeterminate GlobeNewswire, Inc.
No Limits and Swiss Serenity Announce Strategic Partnership to Support Entrepreneurs in Pension Wealth Management
Feb. 9, 2026

No Limits and Swiss Serenity Announce Strategic Partnership to Support Entrepreneurs in Pension Wealth Management

Indeterminate GlobeNewswire, Inc.
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
Feb. 9, 2026

Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology

Indeterminate GlobeNewswire, Inc.
From Boardroom to Build: Radity and StrataFusion Group Partner to Bridge Strategy and Execution in Enterprise Technology
Feb. 9, 2026

From Boardroom to Build: Radity and StrataFusion Group Partner to Bridge Strategy and Execution in Enterprise Technology

Neutral EIN Presswire
WISeKey’s WISe.Art and GMA Once Again Revolutionize the Future of Art and Technology in an Extraordinary Event in Venice
Feb. 9, 2026

WISeKey’s WISe.Art and GMA Once Again Revolutionize the Future of Art and Technology in an Extraordinary Event in Venice

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Launches Free Second Pillar Asset Search Tool
Feb. 5, 2026

Swiss Serenity Launches Free Second Pillar Asset Search Tool

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Publishes Informative Guide on Second Pillar Taxation: Understanding the Tax Rules for Retirement Capital
Feb. 4, 2026

Swiss Serenity Publishes Informative Guide on Second Pillar Taxation: Understanding the Tax Rules for Retirement Capital

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Publishes Comprehensive Guide on LPP Withdrawal for Swiss Expatriates: Withdrawal Rules and Administrative Aspects
Feb. 4, 2026

Swiss Serenity Publishes Comprehensive Guide on LPP Withdrawal for Swiss Expatriates: Withdrawal Rules and Administrative Aspects

Indeterminate GlobeNewswire, Inc.
Swiss Serenity Publishes Informative Guide on Vested Benefits Accounts to Help Swiss Workers Better Understand the Second Pillar
Feb. 3, 2026

Swiss Serenity Publishes Informative Guide on Vested Benefits Accounts to Help Swiss Workers Better Understand the Second Pillar

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions